Jay Duker Net Worth & Insider Trades
Jay Duker - President and CEO, Eyepoint Pharmaceuticals, Inc
What is Jay Duker's Net Worth?
The current estimated net worth of Eyepoint Pharmaceuticals, Inc's President and CEO, Jay Duker, is estimated to be about $331.65K . Jay Duker owns about 17,500 units of Eyepoint Pharmaceuticals, Inc common stock. In the last 5 years at Eyepoint Pharmaceuticals, Inc, Jay Duker has sold an estimated value of $41.57K worth.
What is Jay Duker's Past Insider Trading?
Jay Duker's largest purchase order was 5,000 units , worth over $9.45K on April 3, 2019. In total, Jay Duker has made about 15 transactions over 5 years of their time at Eyepoint Pharmaceuticals, Inc. Jay Duker usually trades in June, with the busiest year in 2019 and 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Jay Duker
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Jay Duker's' Mailing Address?
- Mailing address is C/o Eleven Biotherapeutics 215 1st St. #400 Cambridge MA 02142 MA
Eyepoint Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Nancy Lurker | 2020 | $581,957 | - | $482,460 | $563,216 | $454,508 | $15,660 | $2,097,801 |
| Nancy Lurker | 2019 | $577,037 | - | $650,207 | $693,165 | $144,034 | $15,340 | $2,079,783 |
| George Elston | 2020 | $440,000 | - | - | $83,104 | $236,940 | $15,660 | $775,704 |
| George Elston | 2019 | $58,385 | $20,000 | - | $635,555 | - | $2,068 | $716,008 |
| Dario Paggiarino | 2020 | $436,156 | - | $158,864 | $185,417 | $242,371 | $15,660 | $1,038,468 |
| Dario Paggiarino | 2019 | $420,862 | - | - | $275,775 | $105,188 | $15,340 | $817,165 |
| Scott Jones | 2020 | $376,250 | - | $158,864 | $185,417 | $212,135 | $15,660 | $948,326 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1314102/000156459021022639/eypt-def14a_20210622.htm
What are Eyepoint Pharmaceuticals, Inc's Past Insider Trades?
Eyepoint Pharmaceuticals, Inc's most recent insider trade came on September 6, 2023 by Ew Healthcare Partners Lp, Ew Healthcare Partnersa Lp, Essex Woodlands Fund Ixgp Lp and Essex Woodlands Ix Llc who sold 20,000 units worth $197.98K . In the last 5 years, insiders at Eyepoint Pharmaceuticals, Inc have sold an estimated value of $9.08M and bought an estimated value of $22.04M worth of shares. Insider trading is most common in June, with the busiest year in 2023. The most active traders at the company are Nancy Lurker, Executive Vice Chair, Dario Paggiarino, Chief Medical Officer, and Jay Duker, President and CEO .
EyePoint Pharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||